XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance, shares at Dec. 31, 2021   118,747,447      
Balance, amount at Dec. 31, 2021 $ 32,807,995 $ 118,748 $ 176,586,529 $ (143,951,019) $ 53,737
Net loss (13,106,539) 0 0 (13,106,539) 0
Unrealized loss on debt securities (138,605) 0 0 0 (138,605)
Stock-based compensation 2,350,314 $ 0 2,350,314 0 0
Stock issued for vested restricted stock awards, shares   1,389,677      
Stock issued for vested restricted stock awards, amount 0 $ 1,390 (1,390) 0 0
Shares withheld for taxes on vested restricted stock (196,892) $ 0 (196,892) 0 0
Stock warrants issued for referral agreement 33,043   33,043   0
Proceeds from sale of common stock, net of expenses, amount 0        
Balance, shares at Dec. 31, 2022   120,137,124      
Balance, amount at Dec. 31, 2022 21,749,316 $ 120,138 178,771,604 (157,057,558) (84,868)
Net loss (10,389,653) 0 0 (10,389,653) 0
Unrealized loss on debt securities 84,868 0 0 0 84,868
Stock-based compensation 1,986,296 $ 0 1,986,296 0 0
Stock issued for vested restricted stock awards, shares   1,673,236      
Stock issued for vested restricted stock awards, amount 0 $ 1,671 (1,671) 0 0
Proceeds from sale of common stock, net of expenses, shares   16,000,000      
Proceeds from sale of common stock, net of expenses, amount 3,665,000 $ 16,000 3,649,000    
Shares withheld for taxes on vested restricted stock (166,872)   (166,872) 0 0
AGP Closing of at-the-market sale of common stock, shares   173,558      
AGP Closing of at-the-market sale of common stock, amount 61,136 $ 174 60,962    
Change in fair value of warrants related to vesting (7,905) $ 0 (7,905) 0 0
Balance, shares at Dec. 31, 2023   137,983,918      
Balance, amount at Dec. 31, 2023 $ 16,982,186 $ 137,983 $ 184,291,414 $ (167,447,211) $ 0